MwanzoPHS • FRA
add
Photocure ASA
Bei iliyotangulia
€ 4.24
Bei za siku
€ 4.09 - € 4.09
Bei za mwaka
€ 4.01 - € 6.13
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (NOK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 120.22M | 11.79% |
Matumizi ya uendeshaji wa biashara | 114.55M | 9.62% |
Mapato halisi | -3.47M | 27.61% |
Kiwango cha faida halisi | -2.88 | 35.28% |
Mapato kwa kila hisa | -0.13 | 27.78% |
EBITDA | 5.03M | 50.58% |
Asilimia ya kodi ya mapato | 29.87% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (NOK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 291.05M | 14.11% |
Jumla ya mali | 720.47M | 2.11% |
Jumla ya dhima | 220.74M | -6.73% |
Jumla ya hisa | 499.73M | — |
hisa zilizosalia | 27.11M | — |
Uwiano wa bei na thamani | 0.23 | — |
Faida inayotokana na mali | -0.76% | — |
Faida inayotokana mtaji | -1.05% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (NOK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -3.47M | 27.61% |
Pesa kutokana na shughuli | 34.53M | 298.30% |
Pesa kutokana na uwekezaji | 2.43M | 196.27% |
Pesa kutokana na ufadhili | -12.90M | -28.49% |
Mabadiliko halisi ya pesa taslimu | 24.06M | 718.75% |
Mtiririko huru wa pesa | 25.14M | 5,846.43% |
Kuhusu
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
Ilianzishwa
1993
Tovuti
Wafanyakazi
102
